Zomedica (ZOMDF) Current Deferred Revenue (2021 - 2026)
Zomedica (ZOMDF) recorded Current Deferred Revenue of $363,000 in Q2 2026, up 10.0% from $330,000 a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Current Deferred Revenue (2021 - 2026) Analysis & Trends
At the end of FY2025, Zomedica reported Current Deferred Revenue of $368,000, up 11.2% from FY2024.
- Annual Current Deferred Revenue has increased for four straight years, with a four-year compound annual growth rate of 16.8% (FY2021 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $331,000 in FY2024 (+19.9%), $276,000 in FY2023 (+33.3%), $207,000 in FY2022 (+4.5%) and $198,000 in FY2021.
- Quarterly Current Deferred Revenue has ranged from $148,000 in Q1 2022 to $368,000 in Q4 2025 over the past five years.
- On a year-over-year basis, Current Deferred Revenue has increased for 15 consecutive quarters, with growth averaging 16.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Current Deferred Revenue ranged from 4.5% (Q4 2022) to 66.7% (Q2 2023).
- Per Business Quant, the preceding three quarters came in at $352,000 (Q1 2026), $368,000 (Q4 2025) and $353,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Zomedica | 78.40 Mn | -119.63 Mn | 6.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363,000.00 |
| Mar 31, 2026 | 352,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 331,000.00 |
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 271,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Sep 30, 2023 | 257,000.00 |
| Jun 30, 2023 | 255,000.00 |
| Mar 31, 2023 | 242,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 205,000.00 |
| Jun 30, 2022 | 153,000.00 |
| Mar 31, 2022 | 148,000.00 |
| Dec 31, 2021 | 198,000.00 |
API Access
Zomedica Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();